Overblog
Editer l'article Suivre ce blog Administration + Créer mon blog
Le blog de fukushima-is-still-news

information about Fukushima published in English in Japanese media info publiée en anglais dans la presse japonaise

Thyroid cancer recognised as work-related

December 13, 2018

 

Tepco-linked firm employee’s thyroid cancer caused by work after Fukushima nuclear plant meltdown, labor ministry admits

https://www.japantimes.co.jp/news/2018/12/13/national/tepco-linked-firm-employees-thyroid-cancer-caused-work-fukushima-nuclear-plant-meltdown-labor-ministry-admits/#.XBJRPmlCeos

 

JIJI

The labor ministry said Wednesday that the thyroid cancer of a male worker, exposed to radiation after the triple meltdown at the Fukushima No. 1 plant, has been recognized as a work-related disease.

 

Following the decision by a labor ministry panel of experts, the labor standards inspection office of Hitachi, Ibaraki Prefecture, reached the conclusion on Monday.

 

The man in his 50s became the sixth person to be granted a workers’ accident compensation insurance payment over cancer caused by the March 2011 nuclear disaster at the plant operated by Tokyo Electric Power Co. Holdings Inc. He is the second person to be compensated due to thyroid cancer.

 

According to the ministry, the man, an employee of a Tepco-related company, was taking part in post-accident emergency work at the Fukushima plant that included a power recovery operation. He had worked at several nuclear plants for some 11 years since November 1993.

 

Of his cumulative radiation dose of about 108 millisieverts, he received 100 millisieverts after the meltdown.

 

The man applied for the insurance payment in August 2017, two months after he was diagnosed with cancer.

 

A total of 16 workers have requested such payments due to cancer they say was caused by the nuclear accident. Five have had their requests turned down while another five cases are still pending.

 

Partager cet article
Repost0
Pour être informé des derniers articles, inscrivez vous :
Commenter cet article